MODEX Trademark

Trademark Overview


On Thursday, February 9, 2023, a trademark application was filed for MODEX with the United States Patent and Trademark Office. The USPTO has given the MODEX trademark a serial number of 97788161. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, January 19, 2024. This trademark is owned by ModeX Therapeutics, Inc.. The MODEX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for cancer and infectious diseases

Medical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy
modex

General Information


Serial Number97788161
Word MarkMODEX
Filing DateThursday, February 9, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, January 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals for the prevention and treatment of cancer and infectious diseases; therapeutic pharmaceuticals for the prevention and treatment of cancer and infectious diseases; immunopharmaceuticals for the prevention and treatment of cancer and infectious diseases; vaccines; therapeutic vaccines; multispecific antibodies for medical therapeutic purposes; multi-specific immunotherapeutic pharmaceutical compositions for cancer and infectious diseases
Goods and ServicesMedical research; Research and development of pharmaceuticals; research and development services in the field of antibodies, and immunotherapies for the treatment of cancer and infectious diseases; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; pharmaceutical research and development; vaccine research and development services; research and development in the field of immunotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModeX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events


Event DateEvent Description
Friday, January 19, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 19, 2024LETTER OF SUSPENSION E-MAILED
Friday, January 19, 2024SUSPENSION LETTER WRITTEN
Wednesday, January 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 13, 2023NEW APPLICATION ENTERED